Organizations Filed Purposes:
The Helena Group Foundation seeks to address urgent global issues like environmental degradation, infrastructure security, and the decline of liberal democracy by conceiving and operating non-profit projects alongside a small group of world leaders.
A1R: America in One Room was a historic gathering that brought together the most representative sample of the American voting electorate in U.S. history. Over the course of three full days, this group engaged in a civil and nuanced deliberation on the critical issues facing the United States. The entire sample took the same in-depth questionnaire before and after the event. This process yielded important data concerning how Americans think about values, candidates, and policy issues when given the chance to think deeply, engage with different opinions, and deliberate in a fact-rich and respectful environment. It was covered extensively in the media, and hailed by former US Presidents Barack Obama and Bill Clinton.
Membership Program: Helena's Membership program recruits, convenes, and communicates with a small group of world-leading experts in different fields to help Helena choose and operate our projects to address major global issues. In practice, this means: i) Researching and networking to find potential Helena Members (people who represent the pinnacle of achievement in their and share a willingness to use that influence to achieve positive good); ii)recruiting them to join Helena (and agree to assets and talents to solve world problems); and iii) meeting with members to discuss important global problems, and the ways they can work with each other and with Helena to address those problems (e.g. through our other program services).
SOF: The Social Outcomes Fund project, also known as 'Repurpose', was an effort to pioneer a new financial mechanism for enabling the large-scale repurposing of generic drugs. The United States is suffering from a crisis of drug accessibility and drug affordability. Currently, there are over 7000 diseases with no treatment, prevention, or cure. Developing treatments for these diseases could save lives and vastly reduce healthcare spending. Unfortunately, pharmaceutical products developed today can cost millions of dollars per treatment, making any new treatments largely unaffordable for patients. Generic drug repurposing -- the process of identifying new uses for generic, off-patent drugs--presents an opportunity to uncover breakthrough treatments. Compared to traditional drug development, generic repurposing takes half the time, is 2000 times more likely to succeed, and is 100 times cheaper. Generic drug repurposing can be leveraged to help treat diseases in an affordable and accessible manner. However, up to this point, drug repurposing has been almost impossible because of a lack of financial incentive. This is known as the "Problem of Repurposing". Through Repurpose, Helena developed a financial mechanism and an implementation plan to sustainably enable investment in generic drug repurposing. This financial mechanism uses share-in-savings, driving financial returns from healthcare savings rather than increased spending. This model blazes a trail toward sustainable and affordable drug innovation, and aligns the incentives for drug development with patient health and wellbeing.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Samuel Feinburg | Secretary and Treasurer | 70 | $90,831 |
| Henry Elkus | President | 70 | $90,831 |
| Penny Hintz | Board Member | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202041769349300449_public.xml